BR0015722A - Uso de derivados de pleuromutilina para tratamento transdérmico de doenças bacterianas - Google Patents

Uso de derivados de pleuromutilina para tratamento transdérmico de doenças bacterianas

Info

Publication number
BR0015722A
BR0015722A BR0015722-8A BR0015722A BR0015722A BR 0015722 A BR0015722 A BR 0015722A BR 0015722 A BR0015722 A BR 0015722A BR 0015722 A BR0015722 A BR 0015722A
Authority
BR
Brazil
Prior art keywords
bacterial diseases
transdermal treatment
treatment
transdermal
pleuromutilin derivatives
Prior art date
Application number
BR0015722-8A
Other languages
English (en)
Inventor
Paul Howard Ripley
Erich Zeisl
Stefan Horkovics-Kovats
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8239432&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BR0015722(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of BR0015722A publication Critical patent/BR0015722A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A61K9/0017—Non-human animal skin, e.g. pour-on, spot-on
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Emergency Medicine (AREA)
  • Zoology (AREA)
  • Dermatology (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

"USO DE DERIVADOS DE PLEUROMUTILINA PARA TRATAMENTO TRANSDéRMICO DE DOENçAS BACTERIANAS". Está descrito o uso de um composto da fórmula I onde os substituintes têm os significados dados na reivindicação 1, para a produção de um medicamento para o tratamento transdérmico de infecções bacterianas em seres humanos e animais. Estão ainda descritas composições transdérmicas para o referido tratamento.
BR0015722-8A 1999-11-22 2000-11-20 Uso de derivados de pleuromutilina para tratamento transdérmico de doenças bacterianas BR0015722A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP99123095 1999-11-22
PCT/EP2000/011519 WO2001037828A1 (en) 1999-11-22 2000-11-20 Use of pleuromutilin derivatives for transdermal treatment of bacterial diseases

Publications (1)

Publication Number Publication Date
BR0015722A true BR0015722A (pt) 2002-07-23

Family

ID=8239432

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0015722-8A BR0015722A (pt) 1999-11-22 2000-11-20 Uso de derivados de pleuromutilina para tratamento transdérmico de doenças bacterianas

Country Status (22)

Country Link
US (1) US6852756B1 (pt)
EP (1) EP1231915B1 (pt)
JP (1) JP3892298B2 (pt)
KR (1) KR100529660B1 (pt)
CN (1) CN100344281C (pt)
AR (1) AR026523A1 (pt)
AT (1) ATE289196T1 (pt)
AU (1) AU764451B2 (pt)
BR (1) BR0015722A (pt)
CA (1) CA2386685C (pt)
CO (1) CO5261531A1 (pt)
DE (1) DE60018200T2 (pt)
DK (1) DK1231915T3 (pt)
ES (1) ES2237495T3 (pt)
HK (1) HK1052643B (pt)
MX (1) MXPA02005149A (pt)
NZ (1) NZ518348A (pt)
PT (1) PT1231915E (pt)
RU (1) RU2264812C2 (pt)
TW (1) TWI260220B (pt)
WO (1) WO2001037828A1 (pt)
ZA (1) ZA200203901B (pt)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1399128B1 (en) * 2001-06-15 2006-08-30 Innovent Technology Limited Composition for the treatment of diseases which affect animals' hooves
CO5390081A1 (es) 2001-11-28 2004-04-30 Novartis Ag Compuestos organicos
JP5460947B2 (ja) 2003-09-03 2014-04-02 グラクソ グループ リミテッド 新規調製方法、塩、組成物及び使用
GB0504314D0 (en) 2005-03-02 2005-04-06 Glaxo Group Ltd Novel polymorph
EP1808431A1 (en) * 2006-01-16 2007-07-18 Nabriva Therapeutics Forschungs GmbH Mutilin derivatives and their use as pharmaceutical
CN102415989A (zh) * 2011-09-30 2012-04-18 上海恒丰强动物药业有限公司 盐酸沃尼妙林溶液剂及其制备方法
US11344508B2 (en) 2016-11-09 2022-05-31 Provita Eurotech Ltd Antimicrobial formulations for the improved treatment of veterinary hoof infections
GB201715122D0 (en) * 2017-09-19 2017-11-01 Omnipharm Dev Ltd Topical anti-infective formulation
KR102098289B1 (ko) * 2018-04-11 2020-04-07 경북대학교 산학협력단 발네물린을 유효성분으로 함유하는 골 질환 예방 또는 치료용 조성물
CN109431980A (zh) * 2018-12-27 2019-03-08 山东齐发药业有限公司 一种用于治疗动物皮肤细菌感染的羟啶妙林软膏剂及其制备方法
CN114366732B (zh) * 2022-02-23 2023-08-18 中国医学科学院皮肤病医院(中国医学科学院皮肤病研究所) 泰妙菌素在制备用于治疗银屑病的药物中的应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT301752B (de) * 1969-07-21 1972-09-25 Biochemie Gmbh Verfahren zur Herstellung neuer Pleuromutilin-Derivate
DE2614841A1 (de) 1976-04-06 1977-10-20 Bayer Ag Neue pour-on-formulierungen von anthelmintika
DE3560511D1 (en) * 1984-02-17 1987-10-01 Sandoz Ag Pleuromutilin derivatives, process for their preparation and their use
AT400674B (de) * 1991-07-24 1996-02-26 Biochemie Gmbh Pharmazeutische pleuromutilin-zubereitung
GB9614017D0 (en) * 1996-07-04 1996-09-04 Biochemie Gmbh Organic compounds
GB9807503D0 (en) * 1998-04-07 1998-06-10 Smithkline Beecham Plc Use

Also Published As

Publication number Publication date
TWI260220B (en) 2006-08-21
ES2237495T3 (es) 2005-08-01
MXPA02005149A (es) 2002-11-07
NZ518348A (en) 2003-11-28
ATE289196T1 (de) 2005-03-15
AR026523A1 (es) 2003-02-12
DE60018200D1 (de) 2005-03-24
PT1231915E (pt) 2005-07-29
US6852756B1 (en) 2005-02-08
DK1231915T3 (da) 2005-05-02
CN1391472A (zh) 2003-01-15
JP2003514856A (ja) 2003-04-22
WO2001037828A1 (en) 2001-05-31
HK1052643B (zh) 2008-03-14
AU2836501A (en) 2001-06-04
CO5261531A1 (es) 2003-03-31
JP3892298B2 (ja) 2007-03-14
KR100529660B1 (ko) 2005-11-21
HK1052643A1 (en) 2003-09-26
EP1231915A1 (en) 2002-08-21
DE60018200T2 (de) 2006-01-12
RU2264812C2 (ru) 2005-11-27
CA2386685C (en) 2009-05-19
AU764451B2 (en) 2003-08-21
CA2386685A1 (en) 2001-05-31
EP1231915B1 (en) 2005-02-16
RU2002116252A (ru) 2004-01-20
CN100344281C (zh) 2007-10-24
ZA200203901B (en) 2003-09-23
KR20020053876A (ko) 2002-07-05

Similar Documents

Publication Publication Date Title
BR0215240A (pt) Derivados de calcona e seu uso no tratamento de doenças
BR0214736A (pt) Composto e seus sais farmaceuticamente aceitáveis, composição farmacêutica e método de tratar seres humanos ou animais que sofrem de doenças ou condições
PA8452201A1 (es) Derivados de 9-desoxo-9a-aza-9a -homoeritromicina a c-4"sustituidos.
SE9604786D0 (sv) New compounds
ATE452129T1 (de) N-phenyl-2-pyrimidine-amine derivatives
BR0112591A (pt) Derivados de acridina e sua aplicação como medicamento
BR0309083A (pt) Compostos derivados de benzoxazinona, sua preparação e uso como medicamentos
SE9900961D0 (sv) Novel compounds
NO20002434D0 (no) Oksazolidinonderivater og farmasøytiske preparater
BR0015722A (pt) Uso de derivados de pleuromutilina para tratamento transdérmico de doenças bacterianas
YU13699A (sh) Primena 1-hidroksi-2-piridona za dobijanje leka za lečenje infekcija kože
BR0016430A (pt) Método para o tratamento e/ou prevenção da tosse em um animal de sangue quente, uso de um composto, composto, e, composição farmacêutica
DE69103773D1 (de) Derivate von hydroxaminsäure die lipoxygenase hemmen.
BR0108002A (pt) Derivados de amidas heterocìclicas
DE69317058T2 (de) Die antibiotika ge 37468 a, b und c
BR9908452A (pt) Composição fungicida que compreende uma benzoilfeniluréia
BR0308734A (pt) Composto, composição farmacêutica, uso do composto, e, método para prevenir ou tratar infecção
PT1232173E (pt) Derivados do acido fusidico
BR0215070A (pt) Métodos de tratamento de infecções bacterianas em cães e gatos
ATE117725T1 (de) Antibiotikum ge1655-komplex und seine faktoren a,b und c.
BR0007491A (pt) Uso de 3-isoxazolidinonas e ácidos hidroxilâmicospara o tratamento de infecções
ATE286728T1 (de) Verwendung von homocysteinderivaten zur behandlung von bakteriellen infektionen
BRPI0414454A (pt) agentes antibacterianos
EA200100768A1 (ru) Применение 3-изоксазолидинонов и гидроксиаминокислот для лечения инфекций
EA200000168A1 (ru) Фармацевтическая композиция, снижающая продуцирование белка мср-1

Legal Events

Date Code Title Description
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFIRO O PEDIDO DE ACORDO COM O(S) ARTIGO(S) 8O, 13, 24 E 25 DA LPI.

B12B Appeal against refusal [chapter 12.2 patent gazette]